BEE VECTORING TECH. INTL. WKN: A14WDZ ISIN: CA0765881028 Kürzel: 1UR1 Forum: Aktien Thema: Hauptdiskussion

@Tradeass. Geht mir auch so. Nur so langsam verging mir die Freude an der Idee. Hoffe nur das geht gut aus denn der Anstieg bekam heute einen Dämpfer. 🤨

Bin hier auch seit 2 Jahren mit Spielgeld drin. Bin einfach nur ein Freund der Idee. Dank euch für die Infos!

Auf jeden Fall wird frisches Geld benötigt: Cash per 31.3.2019 (also vor 5 Monaten) = $ 893,633 . https://www.sedar.com/DisplayCompanyDocuments.do?lang=EN&issuerNo=00032646

Hoffentlich wird das Produkt angenommen. Und hoffentlich halten die geflügelten Mitarbeiter den Akkord durch. ;-)

Cool, die Zulassung ist da und kann Umsatz gemacht werden.

Mississauga, ON Canada (August 28, 2019) – Bee Vectoring Technologies International Inc. (the “Company” or “BVT”) (TSXV: BEE) (OTCQB: BEVVF) announced today that the U.S. Environmental Protection Agency has approved Clonostachys rosea CR-7 (CR-7) for use as a fungicide on commercial crops.  CR-7 is the first registered active ingredient for the Canadian-based company and the first active ingredient approved by the EPA for application via bees, known as “bee vectoring,” in which BVT is a global leader. Sold under the brand name VECTORITE™ with CR-7, the product is labeled for numerous high-value crops, including strawberries, blueberries, sunflowers and almonds.  With this approval, BVT is positioned to officially launch and begin to generate revenue with VECTORITE with CR-7, starting with this year’s fall and winter blueberry and strawberry season in the U.S.  The registration permits BVT to make positive crop protection claims when selling VECTORITE with CR-7.   “Not only is this a critical milestone for BVT in terms of the commencement of scalable commercialization and revenue, but it represents a groundbreaking shift in how plant care products can be applied,” said Ashish Malik, CEO of BVT.  “By using commercially reared bees to deliver biological products, growers can protect crops, increase crop yields and enhance their sustainable growing practices by reducing the use of chemicals and other costly and increasingly scarce resources including water, fuel and labor.” BVT is pursuing regulatory approval from other key countries and, because the EPA serves as an affirmative model for regulatory agencies outside the United States, these review processes should move faster and more easily.  “According to industry statistics (1), to establish the high levels of safety and efficacy required to bring a new crop protection product to market costs, on average, more than US $280 million and 11 years of internal research and development, university crop trials, and grower demos. This registration is a valuable and substantial asset for BVT and brings considerable credibility within the industry.” said Michael Collinson, Chairman of the Board of Directors for BVT.  “The BVT team has succeeded in developing a novel and effective alternative solution to traditional chemical pesticides and has done so at a fraction of the average industry cost. We are incredibly pleased to have accomplished this feat and are both proud and excited to put the BVT solution into the hands of farmers in the U.S. and are looking forward to future approvals in major agricultural regions around the world.” The EPA’s registration makes VECTORITE with CR-7, EPA Registration. No. 90641-2, available immediately for sale as a registered fungicide for use on the labelled crops. (1) Source: Report by Phillips McDougall, an independent consultant specializing in market analysis for the agrochemical industry, commissioned by CropLife International (CLI), CropLife America (CLA) and the European Crop Protection Association (ECPA).

Mississauga, ON Canada (August 28, 2019) – Bee Vectoring Technologies International Inc. (the “Company” or “BVT”) (TSXV: BEE) (OTCQB: BEVVF) announced today that the U.S. Environmental Protection Agency has approved Clonostachys rosea CR-7 (CR-7) for use as a fungicide on commercial crops.  CR-7 is the first registered active ingredient for the Canadian-based company and the first active ingredient approved by the EPA for application via bees, known as “bee vectoring,” in which BVT is a global leader. Sold under the brand name VECTORITE™ with CR-7, the product is labeled for numerous high-value crops, including strawberries, blueberries, sunflowers and almonds.  With this approval, BVT is positioned to officially launch and begin to generate revenue with VECTORITE with CR-7, starting with this year’s fall and winter blueberry and strawberry season in the U.S.  The registration permits BVT to make positive crop protection claims when selling VECTORITE with CR-7.   “Not only is this a critical milestone for BVT in terms of the commencement of scalable commercialization and revenue, but it represents a groundbreaking shift in how plant care products can be applied,” said Ashish Malik, CEO of BVT.  “By using commercially reared bees to deliver biological products, growers can protect crops, increase crop yields and enhance their sustainable growing practices by reducing the use of chemicals and other costly and increasingly scarce resources including water, fuel and labor.” BVT is pursuing regulatory approval from other key countries and, because the EPA serves as an affirmative model for regulatory agencies outside the United States, these review processes should move faster and more easily.  “According to industry statistics (1), to establish the high levels of safety and efficacy required to bring a new crop protection product to market costs, on average, more than US $280 million and 11 years of internal research and development, university crop trials, and grower demos. This registration is a valuable and substantial asset for BVT and brings considerable credibility within the industry.” said Michael Collinson, Chairman of the Board of Directors for BVT.  “The BVT team has succeeded in developing a novel and effective alternative solution to traditional chemical pesticides and has done so at a fraction of the average industry cost. We are incredibly pleased to have accomplished this feat and are both proud and excited to put the BVT solution into the hands of farmers in the U.S. and are looking forward to future approvals in major agricultural regions around the world.” The EPA’s registration makes VECTORITE with CR-7, EPA Registration. No. 90641-2, available immediately for sale as a registered fungicide for use on the labelled crops. (1) Source: Report by Phillips McDougall, an independent consultant specializing in market analysis for the agrochemical industry, commissioned by CropLife International (CLI), CropLife America (CLA) and the European Crop Protection Association (ECPA).

Hier noch die Quellenangaben für Alles. Bee: https://www.sedar.com/DisplayProfile.do?lang=EN&issuerType=03&issuerNo=00032646; SD: https://www.sharedeals.de/bee-vectoring-darum-steht-jetzt-der-riesenknall-bevor/; Frühere Pushs zu Bee: https://www.wallstreet-online.de/diskussion/1245356-1-10/rakete-sd-genau-beobachten

Bee braucht bald wieder frisches Geld. Und da nicht eine einzige Bank einen Pfifferlingzu geben scheint...Wie sieht es eigentlich mit Fördergeldern für Bee aus ?? Haben die oder haben die vergessen, welche zu beantragen ?

Aktuell wurden die Warrant von Bee verlängert. Da passt ein Push gut ins Bild, denke ich. Oder etwa nicht ? Hahaha. https://www.finanznachrichten.de/nachrichten-medien/stockwatch.htm

Ich vermute, dass auch in Kanada überwiegend deutsche Trader handeln die Tage. Profis wissens Bescheid. Einmal SD verstehen, immer SD verstehen: Geschäftsmodell Interessenskonflikte. ;-)

Bei einem Push verdienen meist diejenigen, die rechtzeitig ihre Gewinne mitnehmen. Die Disclaimer in diesem Zusammenahng sind es wert, genauer überprüft zu werden...

Die Studien und auch die Lizenz sind noch lange nicht mit einem Markterfolg gleich zu setzen. Das sollte man wissen. Die Aktie wird grad von SD mit einem Artikel im geschlossenen Bereich gepusht. Das erkennt man, wenn man sich anschaut, von wann die Unternehmensmeldungen sind, wie darauf am Mastrkt reagiert wurde und wie nun mit dem Push reagiert wird. Selbst die Kanadier haben nicht wirklich reagiert ! Da mal drüber nachdenken. Hahaha. ;-)

Hallo, kurze Frage, Ich hab gelesen dass "The company is expecting Environmental Protection Agency registration later in 2019, and is hoping to have a global presence by 2022 to 2023." https://investingnews.com/daily/tech-investing/cleantech-investing/bee-vectoring-technologies-testing-honey-bee-system/ Ausserdem habe ich ein Interview von Mr. Malik 2018 auf BBC oder sowas gesehen, wo er ein EPA Genehmigung/Anerkennung schon eher 2019 erwartet hätte. Hat jemand eine Ahnung wann damit zurechnen ist. Eigentlich müsste doch der Termin der Entscheidung fest stehen. Ich glaub da gab es eine weitere Studie ob das Mittel giftig für Larven ist. Diese wurde aber schon im Jan 2019 eingereicht. Gruß

12.9.19: Bee Vectoring muss die Laufzeit von Warrants strecken, da diese sonst am 19. September abgelaufen und damit verfallen wären. Wandlungspreis bleibt gleich. Ende August kommt der nächste Financial Report lt sedar.com. https://www.sedar.com/DisplayCompanyDocuments.do?lang=EN&issuerNo=00032646

Färbt sich bisher ein wenig in Richtung Liebhaberei ein, diese kleine kanadische Butze und ihre Assets. Expansionspläne halte ich für viel zu früh angesetzt. Das erzeugt vor Bestätigung der Rentabilität nur immense Kosten.